# The Medicines for Human Use (Clinical Trials) Regulations 2004, Paragraph 11


In the Dangerous Substances and Preparations (Safety) (Consolidation) Regulations 1994 , in regulation 1 (citation, commencement and interpretation), in paragraph (2), in the definition of “medicinal product”—
(a) for sub-paragraph (ii), substitute the following sub-paragraph—
“(ii) which is an “investigational medicinal product” within the meaning of regulation 2(1) of the Medicines for Human Use (Clinical Trials) Regulations 2003, or”; and
(b) omit sub-paragraph (iii).

---
Source: https://www.legislation.gov.uk/uksi/2004/1031/schedule/10/part/2/paragraph/11 (the official version)
Page: https://openlegislation.uk/medicines-for-human-use-clinical-trials-regulations-2004/schedule-10/part-2/paragraph-11
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.